US
University of Santiago de Compostela at ESGCT 2026
Oct 27–30, 2026 Hamburg, Germany ~2.5k attendees Website
University of Santiago de Compostela brings 5 presentations to ESGCT 2026 in Hamburg. Its work centres on nanocarriers that deliver mRNA to chosen cells, including spleen-directed engineering of T cells for CAR T therapy without ex vivo manufacturing. The same carriers are used to make antibodies inside the body for lymphoma and other cancers.
| Organization | ESGCT 2026 Attendance |
|---|---|
US University of Santiago de Compostela Santiago de Compostela, Spain | |
Poster Wed Oct 28 1:30pm–3:30pm Non-viral mRNA delivery to primary human T cells using nanocarriers as a platform for CAR-T cell manufacturing. Poster Wed Oct 28 1:30pm–3:30pm Spleen-directed Lipid Nanocarriers for in vivo mRNA-mediated T Cell engineering Poster Thu Oct 29 2:00pm–4:00pm Flexible nanocarriers enable brain tissue penetration and cell-specific mRNA delivery in vivo Poster Thu Oct 29 2:00pm–4:00pm Nanocarrier-based anti-BCL6 intracellular antibody therapy for lymphoma treatment Poster Thu Oct 29 2:00pm–4:00pm Nanocarrier-mediated in situ production of an RNA-encoded trispecific antibody combining T-cell engagement and local checkpoint inhibition for cancer immunotherapy |
Instantly find 20 buyers from University of Santiago de Compostela
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the European Society of Gene & Cell Therapy. Submit a correction